longevitywatch
← Back
Research
Eye disease
Immune system

Immune cells linked to age-related blindness

Wet macular degeneration is one of the most common causes of blindness in older age.

LongevityWatch editorsJune 4, 2026

In wet macular degeneration, blood vessels grow in the wrong place inside the retina. They leak and damage the light-sensitive cells responsible for sharp central vision. Existing treatments suppress that blood vessel growth, but do not address the underlying cause. Researchers set out to find what triggers the abnormal vessel growth in the first place.

Natural killer cells as an unexpected factor

Natural killer cells, or NK cells, are immune cells that normally identify and destroy abnormal cells. In healthy tissue, they play a protective role. But the researchers found evidence that NK cells actually contribute to the problem in wet macular degeneration. Elevated numbers of NK cells were present in retinal tissue from patients, and their activity appeared to correlate with the extent of blood vessel growth.

The precise mechanism is not yet fully understood. The NK cells appear to release signals that promote rather than inhibit blood vessel growth. That is unusual behavior for this cell type, and it suggests that the aging retinal environment changes how NK cells function.

A new direction for treatment

If NK cells are indeed a driving factor, that opens a new angle for treatment. Instead of only suppressing the blood vessels themselves, it might be possible to intervene earlier in the process: at the immune response that drives that vessel growth. This could also help prevent relapse after treatment, which is currently a persistent problem.

The findings are still preliminary and based on tissue analysis rather than clinical trials. But they provide a concrete new target for researchers studying the causes of age-related vision loss. Macular degeneration affects tens of millions of people worldwide, and most currently have access only to treatments that manage symptoms.

Read the original article

ShareX / TwitterLinkedIn